Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 12
Submit an article Journal homepage
1,567
Views
22
CrossRef citations to date
0
Altmetric
Author's View - Commissioned

Mutant IDH1: An immunotherapeutic target in tumors

Theresa SchumacherDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology; German Cancer Research Center; Heidelberg, Germany;Department of Neurooncology; University Hospital Heidelberg; Heidelberg, Germany
,
Lukas BunseDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology; German Cancer Research Center; Heidelberg, Germany;Department of Neurooncology; University Hospital Heidelberg; Heidelberg, Germany
,
Wolfgang WickDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology; German Cancer Research Center; Heidelberg, Germany;DKTK Clinical Cooperation Unit Neurooncology; German Cancer Research Center; Heidelberg, Germany
&
Michael PlattenDKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology; German Cancer Research Center; Heidelberg, Germany;Department of Neurooncology; University Hospital Heidelberg; Heidelberg, GermanyCorrespondence[email protected]
Article: e974392 | Received 22 Sep 2014, Accepted 03 Oct 2014, Published online: 07 Jan 2015

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Maria B. Garcia-Fabiani, Maria Ventosa, Andrea Comba, Marianela Candolfi, Alejandro J. Nicola Candia, Mahmoud S. Alghamri, Padma Kadiyala, Stephen Carney, Syed M. Faisal, Anna Schwendeman, James J. Moon, Lindsay Scheetz, Joerg Lahann, Ava Mauser, Pedro R. Lowenstein & Maria G. Castro. (2020) Immunotherapy for gliomas: shedding light on progress in preclinical and clinical development. Expert Opinion on Investigational Drugs 29:7, pages 659-684.
Read now
Erik Ladomersky, Matthew Genet, Lijie Zhai, Galina Gritsina, Kristen L. Lauing, Rishi R. Lulla, Jason Fangusaro, Alicia Lenzen, Priya Kumthekar, Jeffrey J. Raizer, David C. Binder, C. David James & Derek A. Wainwright. (2016) Improving vaccine efficacy against malignant glioma. OncoImmunology 5:8.
Read now
Daniel J. Garama, Tiffany J. Harris, Christine L. White, Fernando J. Rossello, Maher Abdul-Hay, Daniel J. Gough & David E. Levy. (2015) A Synthetic Lethal Interaction between Glutathione Synthesis and Mitochondrial Reactive Oxygen Species Provides a Tumor-Specific Vulnerability Dependent on STAT3. Molecular and Cellular Biology 35:21, pages 3646-3656.
Read now

Articles from other publishers (19)

Nadeem S. Butt, Maher Kurdi, Motaz M. Fadul, Sahar Hakamy, Bassam M.J. Addas, Eyad Faizo, Shadi Alkhayyat, Ahmed K. Bamaga, Taghreed Alsinani, Yousef Katib, Fahad Okal, Yazid Maghrabi, Abdulrahman J. Sabbagh, Rana Moshref, Sultan Albalawi, Alaa Alkhotani, Fawaz Mohammed, Nasser Mulla & Saleh Baeesa. (2023) Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure. Pathology - Research and Practice 250, pages 154816.
Crossref
Lukas Bunse, Theresa Bunse, Christopher Krämer, Yu-Chan Chih & Michael Platten. (2022) Clinical and Translational Advances in Glioma Immunotherapy. Neurotherapeutics 19:6, pages 1799-1817.
Crossref
Pasquale Persico, Elena Lorenzi, Agnese Losurdo, Angelo Dipasquale, Antonio Di Muzio, Pierina Navarria, Federico Pessina, Letterio Salvatore Politi, Giuseppe Lombardi, Armando Santoro & Matteo Simonelli. (2022) Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-Mutations. Cancers 14:5, pages 1125.
Crossref
Nasser K. Yaghi & Mark R. Gilbert. (2022) Immunotherapeutic Approaches for Glioblastoma Treatment. Biomedicines 10:2, pages 427.
Crossref
Michael Kilian, Theresa Bunse, Wolfgang Wick, Michael Platten & Lukas Bunse. (2021) Genetically Modified Cellular Therapies for Malignant Gliomas. International Journal of Molecular Sciences 22:23, pages 12810.
Crossref
Jens Blobner, Michael Kilian, Chin Leng Tan, Katrin Aslan, Khwab Sanghvi, Jochen Meyer, Manuel Fischer, Kristine Jähne, Michael O Breckwoldt, Felix Sahm, Andreas von Deimling, Martin Bendszus, Wolfgang Wick, Michael Platten, Edward Green & Lukas Bunse. (2021) Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodes. Neuro-Oncology Advances 3:1.
Crossref
Zhidong Wang & Yu J. Cao. (2020) Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research. Frontiers in Immunology 11.
Crossref
Elena Cojocaru, Christopher Wilding, Bodil Engelman, Paul Huang & Robin L. Jones. (2020) Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?. Current Molecular Biology Reports 6:1, pages 1-9.
Crossref
Valeria Cuccarini, Luigi Antelmi, Bianca Pollo, Rosina Paterra, Chiara Calatozzolo, Anna Nigri, Francesco DiMeco, Marica Eoli, Gaetano Finocchiaro, Greta Brenna, Irene Tramacere, Maria Grazia Bruzzone & Elena Anghileri. (2019) In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting. Neurological Sciences 41:2, pages 347-355.
Crossref
Serena Tommasini-Ghelfi, Kevin Murnan, Fotini M. KouriAkanksha S. MahajanJasmine L. May & Alexander H. Stegh. (2019) Cancer-associated mutation and beyond: The emerging biology of isocitrate dehydrogenases in human disease. Science Advances 5:5.
Crossref
Jacob S. Young, Fara Dayani, Ramin A. Morshed, Hideho Okada & Manish K. Aghi. (2019) Immunotherapy for High-Grade Gliomas: A Clinical Update and Practical Considerations for Neurosurgeons. World Neurosurgery 124, pages 397-409.
Crossref
Lukas Bunse, Stefan Pusch, Theresa Bunse, Felix Sahm, Khwab Sanghvi, Mirco Friedrich, Dalia Alansary, Jana K. Sonner, Edward Green, Katrin Deumelandt, Michael Kilian, Cyril Neftel, Stefanie Uhlig, Tobias Kessler, Anna von Landenberg, Anna S. Berghoff, Kelly Marsh, Mya Steadman, Dongwei Zhu, Brandon Nicolay, Benedikt Wiestler, Michael O. Breckwoldt, Ruslan Al-Ali, Simone Karcher-Bausch, Matthias Bozza, Iris Oezen, Magdalena Kramer, Jochen Meyer, Antje Habel, Jessica Eisel, Gernot Poschet, Michael Weller, Matthias Preusser, Minou Nadji-Ohl, Niklas Thon, Michael C. Burger, Patrick N. Harter, Miriam Ratliff, Richard Harbottle, Axel Benner, Daniel Schrimpf, Jürgen Okun, Christel Herold-Mende, Sevin Turcan, Stefan Kaulfuss, Holger Hess‐Stumpp, Karen Bieback, Daniel P. Cahill, Karl H. Plate, Daniel Hänggi, Marion Dorsch, Mario L. Suvà, Barbara A. Niemeyer, Andreas von Deimling, Wolfgang Wick & Michael Platten. (2018) Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. Nature Medicine 24:8, pages 1192-1203.
Crossref
Michael Platten, Lukas Bunse, Dennis Riehl, Theresa Bunse, Katharina Ochs & Wolfgang Wick. (2018) Vaccine Strategies in Gliomas. Current Treatment Options in Neurology 20:5.
Crossref
Michael Weller, Patrick Roth, Matthias Preusser, Wolfgang Wick, David A. Reardon, Michael Platten & John H. Sampson. (2017) Vaccine-based immunotherapeutic approaches to gliomas and beyond. Nature Reviews Neurology 13:6, pages 363-374.
Crossref
Fangjun Chen & Fanyan Meng. 2017. Personalized Management of Gastric Cancer. Personalized Management of Gastric Cancer 131 147 .
Chuanbao Zhang, Jiye Li, Haoyuan Wang & Sonya Wei Song. (2016) Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference. Oncotarget 7:45, pages 73971-73983.
Crossref
Qiu-Ju Li, Jin-Quan Cai & Cheng-Yin Liu. (2016) Evolving Molecular Genetics of Glioblastoma. Chinese Medical Journal 129:4, pages 464-471.
Crossref
John H. Sampson & Duane A. Mitchell. (2015) Vaccination strategies for neuro-oncology: Table 1.. Neuro-Oncology 17:suppl 7, pages vii15-vii25.
Crossref
Tej D. Azad, Seyed-Mostafa Razavi, Benjamin Jin, Karen Lee & Gordon Li. (2015) Glioblastoma antigen discovery—foundations for immunotherapy. Journal of Neuro-Oncology 123:3, pages 347-358.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.